𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HER-2/neu Cancer Vaccines: Present Status and Future Prospects

✍ Scribed by Pravin T. P. Kaumaya

Publisher
Springer Netherlands
Year
2006
Tongue
English
Weight
226 KB
Volume
12
Category
Article
ISSN
1573-3149

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Validation of a differential PCR and an
Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer
✍ Pilar F. ValerΓ³n; Ricardo Chirino; Leandro Fernandez; Santiago Torres; Domingo N πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 674 KB

HER-2lneu oncogene status and total cellular p I 8SHER-' content were simultaneously analyzed in 4 I 5 invasive breast-cancer specimens by differential PCR and ELISA respectively. Mathematical analysis of the data led us to establish a cut-off value of I .7 for the ratio between the intensity of the

HER-2/neu status and tumor morphology of
HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry
✍ Louise A. Quenneville; Kelly-Anne Phillips; Hilmi Ozcelik; Robert K. Parkes; Jul πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The prevalence of BRCA1 germline mutations is greater in the Ashkenazi Jewish population than in the general North American population. The Ontario Familial Breast Cancer Registry collects clinical and family history data in familial breast carcinoma cases, and unselected